We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

44 hedge funds and large institutions have $91.2M invested in Eledon Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

360% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 5

63% more funds holding

Funds holding: 27 → 44 (+17)

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

19% more capital invested

Capital invested by funds: $76.8M → $91.2M (+$14.4M)

Holders
44
Holders Change
+17
Holders Change %
+62.96%
% of All Funds
1.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
8
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KCM
Kingdon Capital Management
New York
+$5.32M
2
PA
Perceptive Advisors
New York
+$4.48M
3
BFA
BlackRock Fund Advisors
California
+$2.38M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.32M
5
NHAS
Novo Holdings A/S
Denmark
+$1.52M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$2.92M
2
Jennison Associates
Jennison Associates
New York
-$2.38M
3
Morgan Stanley
Morgan Stanley
New York
-$2.28M
4
SFM
Sphera Funds Management
Israel
-$1.12M
5
Ameriprise
Ameriprise
Minnesota
-$1.02M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$351K +$349K +147 New
TCIM
27
TIAA CREF Investment Management
New York
$311K +$309K +130 New
DCM
28
Destrier Capital Management
New York
$248K – – –
BIM
29
BlackRock Investment Management
Delaware
$233K +$233K +98 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$220K +$218K +92 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$162K +$161K +68 New
Bank of Montreal
32
Bank of Montreal
Ontario, Canada
$118K – – –
TA
33
Teachers Advisors
New York
$89K +$87.8K +37 New
NFA
34
Nationwide Fund Advisors
Ohio
$59K +$59.4K +25 New
AIG
35
American International Group
New York
$54.8K +$54.6K +23 New
Creative Planning
36
Creative Planning
Kansas
$49K – – –
BA
37
BlackRock Advisors
Delaware
$29K +$28.5K +12 New
SO
38
STRS Ohio
Ohio
$29K +$28.5K +12 New
UBS Group
39
UBS Group
Switzerland
$17K +$16.6K +7 New
SFPIA
40
Stevens First Principles Investment Advisors
California
$16K +$4.75K +2 +40%
Citigroup
41
Citigroup
New York
$15K +$4.75K +2 +50%
Barclays
42
Barclays
United Kingdom
$7K +$7.12K +3 New
Morgan Stanley
43
Morgan Stanley
New York
$4K -$2.28M -961 -100%
MAA
44
Managed Account Advisors
New Jersey
$3K – – –
Jennison Associates
45
Jennison Associates
New York
– -$2.38M -970 Closed
Millennium Management
46
Millennium Management
New York
– -$802K -327 Closed
CSS
47
Cubist Systematic Strategies
Connecticut
– -$252K -103 Closed
SIM
48
Spark Investment Management
New York
– -$155K -64 Closed
TRCT
49
Tower Research Capital (TRC)
New York
– -$3K -1 Closed
1
2

ELDN Hedge Fund Activity: Q4 2014 in Review

44 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q4 2014, worth a combined $91.2M — up 19% from $76.8M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new ELDN positions and 5 closed out — a net gain of 18 holders — while 8 added to existing stakes and 6 trimmed.

The largest buyer was Kingdon Capital Management, adding an estimated $5.32M. The largest seller was Redmile Group, cutting an estimated $2.92M.

  • 44 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q4 2014, up from 27 in Q3 2014.
  • Funds reported $91.2M of Eledon Pharmaceuticals stock for Q4 2014, up 19% quarter-over-quarter.
  • 23 funds opened new Eledon Pharmaceuticals positions in Q4 2014 and 5 closed out, a net change of +18 holders.
  • The largest Eledon Pharmaceuticals buyer in Q4 2014 was Kingdon Capital Management, an estimated $5.32M added.
  • The largest Eledon Pharmaceuticals seller in Q4 2014 was Redmile Group, an estimated $2.92M sold.

Based on aggregated 13F filings for Q4 2014.